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12.30pm – 3.30pm APPEL Preceptor Training – Supporting 4th-year Student Pharmacists on their Journey to PracticeDr Maria Donovan & Eimear Ni Sheachnasaigh  |   The Burren
3.00pm – 6.00pm Registration 
3.30pm – 4.00pm Exhibition Hall; Tea/Coffee/Water   |   Inis Mór 1&2
4.00pm – 5.00pm
Maximising the Return from your Dispensary Data – a hmR Presentation
Alan McCormick   |   Veranda Lounge 
5 Ways to Increase Your Wellbeing at Work (No Matter How Busy You Are)
Séamus Ruane MPSI   |   Inis Mór 3
5.00pm – 5.30pm Exhibition Hall; Tea/Coffee/Water   |   Inis Mór 1&2
5.30pm – 6.30pm The Pharmacist in an Atrial Fibrillation Clinic . . . A Model of CareEdwina Morrisey & Dr Rónán Collins   |   Sponsored by Bristol Myers Squibb   |   Inis Mór 3
7.00pm – 8.00pm Exhibition Hall; Pre-Dinner drinks   |  Inis Mór 1&2
8.00pm Dinner  Marinas Grill 
SATURDAY 11 MAY
8.00am – 1.30pm Registration
8.00am – 8.30am Exhibition Hall; Tea/Coffee/Water  |   Inis Mór 1&2
8.30am – 9.30am
Transform your Business using People, Process and Technology Jay Patel   |   Inis Mór 3
The Role of the Community Pharmacy Team in Supporting Palliative Care at Home
Karen McKee   |   In Association with the Galway Hospice   |   Veranda Lounge 
9.30am – 10.00am Exhibition Hall; Tea/Coffee/Water   |   Inis Mór 1&2
10.00am – 12.00pm Plenary Session  |   Simon Harris T.D, Darragh O’Loughlin, Robert Tsuyuki, Margaret Wing & Terence A. Maguire   |   Inis Mór 3
12.00pm – 12.30pm Exhibition Hall; Tea/Coffee/Water   |   Inis Mór 1&2
12.30pm – 1.30pm
Economic Trends in 2019 and How they May Affect the Pharmacy Sector
Jim Power   |   In Association with Moore Wealth Management   |   Veranda Lounge 
Eczema Diagnosis and Treatment: Tips and Tricks for the Community Pharmacist
Dr Paul Ryan   |   Sponsored by A.Menarini   |   Inis Mór 3
1.30pm – 2.15pm Lunch  |   Marinas Grill
2.15pm – 3.00pm Exhibition Hall; Dessert   |   Inis Mór 1&2
3.00pm – 4.15pm Panel Discussion: Sláintecare – The Future Shape of HealthcareLaura Magahy, Terence A. Maguire, Aileen Bryson & Daragh Connolly  |   Veranda Lounge 
4.15pm – 5.15pm Leading Through Adversity Jack Kavanagh   |   Veranda Lounge 
7.00pm Pre-Dinner Drinks Reception   |   Inis Mór Pre-Conference Area
8.00pm President’s Dinner & Ball   |   Inis Mór Ballroom
SUNDAY 12 MAY
9.30am – 11.15am Registration
10.00am – 11.00am
Leading, Delegating, Communicating – How will you Manage? Susan Madden   |   Inis Mór 1
The Challenges Presented by Breast Cancer Survivors Taking Antihormone Medication    
Elizabeth Summersby   |   Inis Mór 3
11.00am – 11.15am Tea/Coffee/Water   |   Inis Mór Pre-Conference Area
11.15am – 1.15pm IPU AGM – Reports & Motions   |   Inis Mór 3
11.15am – 12.45pm Support and Care for Cancer Patients – CPD for Pharmacy Technicians  
Sheila O’Driscoll   |   Inis Mór 1
1.15pm Lunch  |   Marinas Grill
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2019 IPU AGM AND IPU 
SERVICES LTD AGM
11.15AM – 1.15PM SUNDAY 12 MAY
(confined to paid-up members of the IPU)
11.15am 1. Welcome
2. One minute’s silence in memory of pharmacists who died since the 2018 AGM
3. Minutes of IPU 2018 AGM*
4. Minutes of IPU Services Ltd 2018 AGM*
5. Financial Report and Consolidated Accounts 2018
a. Adoption of Audited Statement of Accounts of IPU
b. Appointment of Auditors of IPU and IPU Services Ltd
c. Adoption of Directors’ Report and Audited Statement of Accounts of IPU Services Ltd
11.30am 6. Overview from the Secretary General
11.40am 7. Group Reports / Open Forum: Introduction and Update
a. Pharmacy Contractors’ Committee Report
b. Community Pharmacy Committee Report
c. Employee Pharmacists’ Committee Report
d. Communications Report*
e. International Pharmacy Matters*
12.00pm 9. Report on Motions from 2018 AGM*
12.05pm 10. 2019 AGM Motions
1.05pm 11. Open Forum
1.15pm Closing of AGM Procedures by IPU President Daragh Connolly
* These items are contained in a more detailed report on www.ipu.ie.
AGENDA
Chairperson: : Mr Daragh Connolly, President
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MESSAGE FROM  
THE PRESIDENT  
DARAGH CONNOLLY
It gives me great pleasure to welcome you to the annual IPU National 
Pharmacy Conference on its return to Galway, City of the Tribes and to  
present the IPU Annual Report which gives in great detail the work  
undertaken on your behalf by the Committees and staff of the IPU.
Dear Colleagues and Friends,
As I write, we await the tortured outcome of 
Brexit negotiations. It is abundantly evident that 
we, as a nation, have a very clear vision for our 
place in Europe and the world. As pharmacists, 
we fear the disruption Brexit could bring to our 
practices and to the exceptional continuity of 
care we deliver to our communities. On your 
behalf, the IPU has worked very closely with 
the HPRA, PSI and Department of Health to 
plan and mitigate for the inevitable disruption 
Brexit will cause. In the broader context Brexit 
evidences that, without a clear vision for its 
future driven by a consensus from its members 
based on realism and an understanding of 
other stakeholders, no representative body can 
achieve any of its objectives. I am very proud of 
the fact that the IPU remains the singular and 
authoritative voice of community pharmacy in 
Ireland, enjoying the overwhelming support of 
our members for our clear vision for the role 
and future of community pharmacists in Ireland.
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A singular vision for the future of healthcare in 
Ireland exists and enjoys a cross party consensus 
and, simply put, Sláintecare identifies that 
the only way to fix our healthcare system is 
to invest in primary care. To date, the singular 
failure of Sláintecare is to “care for the 
people who care for the people”: the failure 
to reverse the FEMPI cuts that have left one 
in five hospital consultants positions vacant; 
young physicians turning their backs on a 
career in general practice, leading to three 
quarters of family practices being closed to 
new patients; and more than 300 community 
pharmacies, particularly in deprived and isolated 
communities, being unviable. Pharmacists 
young and old have shared their despondency 
about their futures in community practice 
through our in-depth study conducted on 
our behalf by Behaviour and Attitudes. 
Their opinions have laid out their day to day 
experiences and frustrations with HSE/
PCRS red tape which takes so much of their 
valuable time and only result in denying their 
patients timely and appropriate healthcare. 
The contempt with which care-givers are 
treated, whether consultants, physicians or 
pharmacists, is no basis to build a future for our 
healthcare system. We have made our position 
abundantly clear to the HSE/PCRS that we 
cannot progress to give more value to the Irish 
people until they adopt a professional attitude 
becoming of their monopsonistic position.
Despite the intransigence of the HSE/PCRS, 
it shone through from our survey that being 
a community pharmacist remains a highly 
rewarding area of professional practice. The 
time we spend with our patients remains, as it 
has done for centuries, the cornerstone of our 
satisfaction as we help them and their families 
get the most from their health by being expert, 
relevant and accessible.
Pharmacists are overwhelmingly in favour 
of working to full scope and would relish 
the challenge to add more and more value 
to their communities’ healthcare by being 
freed to practice as colleagues do in Scotland, 
Canada and New Zealand. These ambitions are 
completely aligned with Sláintecare and our 
initial engagements with those charged with its 
implementation have been positive. 
As ever the IPU will continue work with our 
partners and advocate for an equitable and 
sustainable future for community pharmacy 
which utilises to our fullest potential the 
accessibility and expertise and willingness of 
community pharmacists.
I was hugely heartened for the future of our 
profession through our collaboration with the 
Irish Pharmacy Students Association. It has 
always been the advice to the PSI from the 
Community Pharmacists Committee of the 
IPU that employer/employee relationship 
enjoyed by generations of pharmacists both at 
the outset and during their professional lives 
should not be restricted. Through very effective 
and coherent advocacy from both students 
and the IPU, the ban on payment of pharmacy 
students on work placement was reversed.  
To build on such a positive collaboration I will 
bring a motion to our conference to open 
Associate membership of the IPU to Irish 
pharmacy students so we can work more 
closely in the future.
We have lost esteemed colleagues since we last 
met in Wexford. I am reminded, through our 
work with the IPSA, that our former President 
and Trustee, Diarmuid O’Donovan MPSI, who 
sadly passed away suddenly in December, had 
been a tutor to 32 pharmacy interns during 
his career. Diarmuid’s unassuming and tireless 
dedication to his family, community, union and 
profession will be sadly missed, but his legacy 
will live on through his family, his community, 
his union and his profession, not just those 32 
interns he helped become pharmacists.
The practice of community pharmacy in Ireland 
is in good hands. I and everyone in the IPU 
will continue to work tirelessly to advocate for 
pharmacists to achieve their full potential at 
every stage of their careers and to be properly 
rewarded for their efforts. With your continued 
support, our Union will build on our vision and 
successes for our futures, our families, our 
communities and our profession.




2018 AGM MOTIONS 
AND REPORT ON 
ACTION TAKEN
The following motions were proposed in accordance 
with Article 30 of the Constitution. All motions  
were debated and considered by the meeting and  
then passed.
1. “That this AGM calls upon the Department 
of Health and the Department of Public 
Expenditure and Reform to commence 
without any further obfuscation or delay a 
process to reverse FEMPI as it applies to 
community pharmacy contractors.”
 Proposed:  Eoghan Hanly
 Seconded:  Michael Tierney
 The reversal of FEMPI is a key objective 
for the IPU. Since the last AGM we 
made a detailed submission to the 
Department of Health setting out the 
case why FEMPI needs to be reversed 
for community pharmacy contractors. 
We had meetings with the Minister for 
Health, Department of Health Officials 
and Opposition Spokespersons on Health 
setting out, the effect FEMPI has had on 
community pharmacy and calling upon 
them to immediately commence the 
unwinding of FEMPI in recognition of the 
contribution pharmacy contractors have 
made in achieving significant savings for 
the state during the financial crisis. We 
outlined at every opportunity, that with the 
improvement in the economy generally, it is 
beyond time that the findings of the 2008 
Dorgan report, index linked to the present 
should be implemented.
 We have now got a commitment from the 
Minister for Health that he will engage with 
the IPU this year to commence the process 
of unwinding of FEMPI.
2. “That this AGM calls upon the Department 
of Health to address health service capacity 
challenges and improve patient care through 
the introduction of properly resourced 
pharmacy-based services.”
 Proposed:  Daragh Connolly
 Seconded:  Aidan Walsh
 Since the last AGM, we made submissions 
to the Department of Health on the 
Expansion of the Pharmacy Vaccination 
Service, Health Service Reform and 
Implementation of Sláintecare, and a 
Service to Identify Hypertension and Atrial 
Fibrillation in the Community.
 We met with the Executive Director of 
Sláintecare in October 2018 to put at 
their disposal the network of community 
pharmacies throughout Ireland to help 
them deliver convenient, accessible, high 
quality healthcare in every town, village and 
community in the country. We outlined the 
details of our proposals for a Minor Ailment 
Scheme, New Medicine Service and Access 
to Contraception. We presented a Proposal 
for a Community Pharmacy-Based Triage 
Programme to the Executive Director 
of Sláintecare in March 2019, outlining 
the triage services that could be offered 
in a community pharmacy: responding 
to symptoms (minor ailment scheme); 
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 We had an official meeting with the 
Department of Health in December 2018 
to discuss a number of the proposals that 
we have made over the past few years in 
relation to enhanced pharmacy services: 
Minor Ailment Scheme, Access to 
Contraception, NMS, MUR and broadening 
existing Vaccination services. At a meeting 
with the National Immunisation Office in 
March 2019, it was confirmed that it was 
now Department of Health policy that an 
HSE-reimbursed pharmacy pneumococcal 
vaccination service be introduced. The HSE 
is working to make this happen by October 
2019. We are part of the HSE Working 
Group to establish treatment of patients 
with hepatitis C in community settings. It 
is intended to start rolling out the service in 
May 2019 to methadone patients.
 At our meeting with the Minister for 
Health in March 2019, the Minister 
indicated that any new service would have 
to demonstrate a return on investment 
and would need to be backed up by data 
and research. We discussed in detail 
services such as Minor Ailment Scheme, 
New Medicine Service and Expanded 
Vaccination. The Minister clarified that 
there is a big push from Government 
to align all primary care services to the 
Sláintecare action plan for 2019.
3. “That this AGM calls upon the Department of 
Health and Health Service Executive to put 
in place a scheme to enable women to access 
contraception directly from their community 
pharmacist without prescription and without 
charge, regardless of eligibility.”
 Proposed:  Elizabeth Lang
 Seconded:  Sheila O’Loughlin
 In April 2018, we made a proposal to the 
Department of Health for a scheme by 
which women could access contraception 
directly from their community pharmacist 
without prescription and without charge. 
When the Minister for Health announced 
the setting up of a Working Group on 
Access to Contraception in February 2019, 
we proposed that the IPU be represented 
on the Working Group. We reiterated this 
proposal at a meeting with the Minister in 
March 2019.
 
 The Minister replied in a letter on 29 
March 2019, confirming that the Working 
Group is an internal group consisting of 
officials from the Department of Health 
but that an essential part of its work will be 
to consult fully and comprehensively with 
all stakeholders. The Minister commented 
that the IPU’s willingness to engage and 
contribute on this topic is very welcome 
and that the consultation process will 
enable the IPU to contribute fully to the 
work of the Group in the development of 
accessible, high-quality and cost-effective 
contraception services.
 At our meeting with the Minister in March 
2019, the Minister confirmed that the 
Working Group will report to the Minister 
by September 2019 to enable the Minister 
to include the relevant costs in the budget 
and it is hoped to have roll out of a service 
early 2020.
4. “That this AGM calls upon the Department 
of Health to amend current legislation to 
allow community pharmacists to substitute 
reference biological medicines with 
biosimilars.”
 Proposed:  Brendan Quinn
 Seconded:  Anna Kelly
 Further to the submission we made 
to the Department of Health’s public 
consultation on a National Biosimilar Policy 
in September 2017, we released a number 
of press statements over the last year, 
highlighting that if pharmacists were allowed 
to substitute biosimilars for reference 
biological medicines, the State could realise 
a potential saving of €370 million over the 
next three years with optimum biosimilar 
entry and penetration.
 As part of a submission we made to the 
Joint Committee on Health in April 2019 
on proposed amendments to the Health 
(Pricing and Supply of Medical Goods) Act, 
we proposed deletion of sections of the Act 
that prohibit pharmacists from substituting 




5. “That this AGM calls upon all superintendent 
pharmacists to suspend completion of the 
PSI’s pharmacy assessment folder pending a 
full review and consultations between the IPU, 
superintendents and the PSI.”
 Proposed:  Margaret O’Doherty
 Seconded:  David Jordan
 The PSI conducted a review of the 
Pharmacy Assessment System through 
a public consultation in May 2018. They 
concluded that, from January 2019, the 
completion of the Pharmacy Assessment 
System would be reduced to once annually. 
Pharmacies received an updated set of 
booklets in March 2019. Alternatively, 
pharmacies can use the editable PDF 
version of the Pharmacy Assessment 
System available on the PSI website.
6. “That this AGM calls upon the IPU members 
not to cooperate with the PCRS in certain 
Administrative tasks, such as the online 
completion of the high tech stocktake, until 
the PCRS agrees to consult and agree with 
the IPU prior to making any changes which 
affect current practice.”
 Proposed:  David Jordan
 Seconded:  Michael Tierney
 The amended motion was put to the 
meeting and passed with three abstentions 
and one vote against.
 Since the last AGM the PCRS has engaged 
with the IPU through a number of fora 
including the Joint Consultative Group and 
the Joint Operational Group. The Pharmacy 
Contractors and Executive Committee 
have committed to a process of strategic 
reengagement with the PCRS. The PCRS 
has now formally acknowledged the role of 
community pharmacists in patient care and 
made commitments on new services and 
also committed to working to improve our 
relationship with the Department of Health 
in order to make progress on contractual 
reform and the unwinding of FEMPI. There 
was no strategic advantage to the IPU 
withdrawing from these administrative tasks 
during the past year but the matter will be 
kept in reserve and implemented if deemed 
necessary by the Executive Committee.
7. “That this AGM calls on the IPU to engage 
with the Higher Education Authority to 
demand that they fund all five years of the 
five-year Masters’ Degree Programme in 
Pharmacy.”
 Proposed:  Richard Collis
 Seconded:  Edward MacManus
 We wrote to the Higher Education 
Authority (HEA) in June 2018, urging them 
to reconsider their decision not to fund the 
final year of the five-year Masters’ Degree 
Programme in Pharmacy. We made it clear 
that the combination of increased fees 
and the fact that the internship is unpaid 
means it is not feasible for students from 
disadvantaged backgrounds to complete the 
pharmacy course.
 The HEA responded to our letter in July 
2018, confirming that the Free Fees 
Initiative criteria clearly state that, “Tuition 
fees will be paid in respect only of students 
attending full-time undergraduate courses 
(up to Level 8)”. Furthermore, the HEA had 
written to all universities clarifying that if 
the final year(s) of an undergraduate course 
led to a Level 9 qualification, those years 
would not qualify for free tuition fees.
 We participated in the 4th year pharmacy 
students’ protest event and march in 
January 2019 in relation to payment for 
their intern placement. Following the march, 
the PSI and APPEL confirmed that, despite 
previous advice to the contrary, APPEL 
will not stipulate either non-payment or 
payment of placements and this will be a 
matter for placement providers to consider.
8. “That this AGM calls on the IPU to stand up 
for pharmacists and to demand and to deliver 
the end of the scapegoating of pharmacists by 
the PSI and other State bodies”
 Proposed:  Michael Austin
 Seconded:  Edward MacManus
 This motion was withdrawn and referred to 
the Executive Committee. The Executive 
Committee at their meeting of the 27 June 
2018 discussed and considered the relevant 
motion and agreed no further actions would 
be taken on this motion.
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9. “That this AGM calls on the IPU to demand 
and deliver the reduction of PSI fees to  
reflect current economic reality and  
fees internationally.”
 Proposed:  Edward MacManus
 Seconded:  Richard Collis
 This motion was withdrawn and referred to 
the Executive Committee. The Executive 
Committee at their meeting of the 27 June 
2018 discussed and considered the relevant 
motion and agreed no further actions would 
be taken on this motion.
10. “That this AGM calls on the IPU to demand 
and deliver the implementation of the parts  
of the 2006 IPHA agreement that penalise 
drug companies for shortages.”
 Proposed:  Edward MacManus
 Seconded:  Michael Austin
 This motion was withdrawn and referred to 
the Executive Committee. The Executive 
Committee at their meeting of the 27 June 
2018 discussed and considered the relevant 
motion and agreed no further actions would 
be taken on this motion.
11. “That this AGM calls on the Minister for 
Health to engage with the IPU to deliver 
reform of the Health Service by utilising 
pharmacists as a core part of the primary 
care network.”
 Proposed:  Roy Hogan
 Seconded:  Michael Austin
 This motion was withdrawn and referred to 
the Executive Committee. The Executive 
Committee at their meeting of the 27 June 
2018 discussed and considered the relevant 
motion and agreed no further actions would 
be taken on this motion.
12. “That this AGM condemns the current 
duopoly of wholesalers that has destroyed 
competition in the sector, reduced margins, 
standards and returns while increasing  
drug shortages.”
 Proposed:  Roy Hogan
 Seconded:  Michael Austin
 This motion was withdrawn and referred to 
the Executive Committee. The Executive 
Committee at their meeting of the 27 June 
2018 discussed and considered the relevant 
motion and agreed no further actions would 
be taken on this motion.
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EXECUTIVE SUMMARY
OVERVIEW FROM THE 
SECRETARY GENERAL  
DARRAGH O’LOUGHLIN
1. INTRODUCTION 
In 2018, Ireland had the fastest growing 
economy in the euro zone for a fifth straight 
year. Yet again, however, the economic 
improvements were not reflected in 
pharmacy fortunes, which have continued 
to deteriorate, due largely to downward 
movement in medicine prices and a squeeze 
on pharmacy reimbursements, coupled with 
higher business costs and salary inflation 
which is fuelled by increases in public sector 
salaries and the minimum wage. Research and 
analysis carried out for the IPU by EY-DKM 
Economic Consultants and Smith & Williamson 
accountants towards the end of 2017 indicated 
that pharmacies directly employ approximately 
9,140 full-time and 7,300 part-time staff, 
and the sector’s combined direct, indirect and 
induced contribution to national GDP exceeds 
€2 billion. However, financial sustainability 
remains a real concern for many pharmacy 
businesses and we have seen a number of 
business failures since last year’s AGM.
2018 was a very difficult year 
in the relationship between 
the IPU and the HSE 
PCRS. Having previously 
reached agreement with 
them on a project due to 
be rolled out last year to 
enhance the electronic 
interface between 
pharmacy contractors 
and the PCRS, with 
initial deliverables 
including full visibility 
in dispensary systems 
of patient eligibility 
and patient-specific 
approvals, electronic 
submission of Dental 
and EU claims, 
managing owings, 
and enhanced XML payment listing to allow 
pharmacy systems to fully reconcile claims and 
payments, we told the HSE PCRS in February 
2018 that we were suspending our cooperation 
with this project.
Following a stand-off throughout the year, 
during which the HSE increased its inspection 
activity substantially and subjected individual 
pharmacists to ever-closer scrutiny, and IPU 
proposals to Government regarding health 
service reform were ignored and correspondence 
went un-answered as we were effectively frozen 
out of discussions, the Executive Committee 
and Pharmacy Contractors’ Committee made 
a decision in October to strategically re-engage 
with the HSE on a broad agenda including the 
Interface Project in an effort to progress our 
relationship with the Department of Health. 
Since then, there has been some progress: we 
are now involved in discussions on new services 
such as the transfer of treatment for Hepatitis 
C from hospital to community pharmacy and we 
have had several constructive meetings with the 
Sláintecare Implementation Office on service 
reform and with the Minister for Health and  
his Department on the future relationship  
with pharmacy.
Since 2009, pharmacies have suffered almost 
a decade of decline. Pharmacists have delivered 
substantial productivity and efficiency gains, 
under a growing regulatory and administrative 
burden and in the face of increased demand and 
greatly reduced fees and revenues. The latest 
HSE PCRS statistics show that since 2009 per 
item dispensing fees have fallen by a sixth and 
fees paid per pharmacy have fallen by the same 
amount. Pharmacy medicine prices have fallen 
by 35.7% and the overall pharmacy medicines 
bill has fallen 28.1%, with an increase of 11.7% in 
items dispensed.
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Despite pharmacists’ cooperation with ever-
tightening audit and validation obligations 
and increased administrative workload, and 
notwithstanding previous Government 
commitments, no reversal of FEMPI cuts 
to pharmacists’ payments has yet been 
implemented. Achieving equitable treatment 
through an unwinding of these cuts remains 
the key focus of the IPU. We have lobbied 
extensively on the issue and have secured a 
Ministerial commitment that the process of 
engagement on the unwinding of FEMPI and 
contractual reform will begin in the current year 
and that pharmacy funding will move to “higher 
terrain”. The recently announced agreement 
between Government and the IMO, which 
provides for a staged reversal of cuts to GP fees, 
will set our expectations.
The IPU exists only to serve the interests of its 
members. There are comprehensive reports in 
this publication which illustrate the wide range of 
activities that the IPU engages in. The Executive 
Committee which oversees the management 
of the IPU and the work of the three main 
IPU Committees – the Community Pharmacy 
Committee, Employee Pharmacists’ Committee 
and Pharmacy Contractors’ Committee – 
ensures the IPU’s continued importance to and 
focus on the needs of practising pharmacists. 
The new IPU Statement of Strategy adopted 
by the Executive Committee in 2017 commits 
us to making community pharmacy the 
driving force at the centre of the evolution 
of accessible, equitable and patient-focussed 
primary healthcare, with clear and measurable 
objectives which will be reported on to all 
members.
The members of the IPU’s various committees 
and sub-committees have worked hard all year 
to support, advance and protect the community 
pharmacy profession. The term of office of 
the current committees will finish at the end 
of 2019. We are lucky to have a great mix of 
pharmacists of ability and integrity volunteering 
to serve on IPU committees on behalf of 
all members – keeping the perspective and 
concerns of everyday practising pharmacists to 
the fore – and we hope that they will remain 
willing to do so into the future. The pooling of 
members’ ideas, efforts and resources, matched 
with the enthusiasm of the pharmacists who give 
generously of their time, energy and experience, 
ensures that all pharmacists benefit from IPU 
support in their practices and their businesses 
and also ensures that we are here to advise and 
assist individual members whenever you need us.
2. MEMBERSHIP & PHARMACY OWNERSHIP (AS AT 11 MARCH 2019)
a. Membership of the IPU
Community Proprietors 856
Industry & Wholesale 3
Community Employees 1436*
Hospital 0
Army, Academic & Admin   2
Associate Members 2 2,282


























of the IPU 
Product File
Notes on Employee Membership
787 are Supervising Pharmacists availing of the free membership for additional pharmacies. Three are 
Supervising Pharmacists in non-pharmacist owned pharmacies and are covered by the sub paid by the 
pharmacy. 76 are availing of the free first-year membership. 19 are joint pharmacy owners who pay a  
CE subscription.
3. ADMINISTRATION UNIT
The Administration Unit has three staff 
members. Róisín Molloy is responsible for all 
aspects of membership and the management 
of the Secretary General’s office. Patrice 
O’Connor looks after membership support and 
assists in the day-to-day running of the office. 
Ciara Enright, who works part-time as the 
IPU’s accountant, is Secretary to the Finance 
Committee. She maintains books of account 
and advises members on a range of taxation and 
accountancy issues.
4. IPU PRODUCT  
FILE UNIT
The IPU Product File is managed by 
Fiona Hannigan and her team: Ger Gahan, 
Tara Kelly, Eilish Barrett and Alan Collins. As 
well as supplying price updates and product 
information for members, they provide the 
following services and advice:
 • Product sourcing;
 • General queries on the IPU Product File;
 • GMS pricing issues;
 • Medicine Shortages; and
 • Discontinued Lists.
IPU Product File Update
•  ISO Certification awarded to IPU 
 Product File
•  Continued certification to ISO    
27001:2013 and ISO 9001:2015 
 a warded February 2019.
•  ISO Certification maintained, through   
quarterly audits.
•  IPU Product File Distribution
•  Work on developing a new distribution   
method for the IPU Product File is   
complete;
•  Piloting has begun on Web Service   
Distribution; and
•  The FTP download of the IPU Product   
File will cease from September 2019.
•  Enhancements to the IPU Product File
•   Virtual Medicinal Product(VMP)
Classification is now complete and is 
available via Web Service Distribution.
•  SNOMED mapping is complete on the IPU 
Product File for Dose Form and Route of 
Administration and the process of mapping to 
Substance has commenced. We are working 
with SNOMED Ireland to included IPU 
Product File information in the first official 
SNOMED CT file for Ireland in April 2019.
c. Total Number of Chains (2 and over)
Two pharmacies 123 6 258
Three 44 132
Four 17 1 72
Five 12 60
Six     5 1 36
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•  A web portal is being developed to allow 
manufacturers, suppliers and other licence 




The Contract Unit consists of 
two staff members, Derek Reilly, Contract 
Manager and Secretary to the Pharmacy 
Contractors’ Committee (PCC), and Aoife 
Garrigan, Contract Administrator.
As PCC Secretary, Derek plays a key role in 
developing and promoting PCC initiatives and 
the resolution of issues arising with the HSE 
PCRS and the Department of Health. The 
Contract Unit spent much of the year liaising 
directly with the HSE PCRS on behalf of 
individual members in an effort to resolve the 
numerous contractual queries and payment 
issues that arose.
In addition to assisting with the above, Aoife 
is responsible for compiling information on 
raids and robberies that have occurred and 
highlighting any trends which can be identified. 
She is also responsible for notifying members of 




Jim Curran, as Director 
of Communications & Strategy, oversees the 
IPU’s internal and external communications 
and is responsible for developing the IPU’s 
strategy. The Communications Team, which 
includes Siobhán Kane and Ciara Browne, is 
responsible for promoting the interests of the 
IPU and the membership through effective 
communications with members, media, the 
public and other parties that influence the 
sector. Jim is responsible for overseeing business 
development and policy research, as well as the 
strategy statement for the IPU, which covers 
the period 2017 – 2021. Jim is also Secretary to 
the Executive Committee and represents the 
IPU in numerous external forums.
Siobhán Kane is Press and Communications 
Manager and is responsible for coordinating the 
communication activities for the IPU across 
multiple channels. She is also responsible for 
the IPU’s public relations and dealing with the 
media, as well as IPU publications, particularly 
the IPU Review and the Annual Report. 
While Siobhán is on maternity leave, Sinéad 
Fennell joined the IPU in August 2018 to cover 
for Siobhán as Press and Communications 
Manager.
Ciara Browne as Communications and Events 
Executive is responsible for the managing 
and coordinating of the annual IPU National 
Pharmacy Conference. She coordinates 
advertising campaigns for the IPU, maintains 
the IPU’s presence on social media channels, 
manages the IPU website, www.ipu.ie, and is an 
editorial associate of the IPU Review. Ciara is 
also responsible for the production of IPU News 
(the weekly eNewsletter) and the monthly GM.
Communications update since  
the last AGM
•  Communications with Members:
 Communications with members continue to 
improve, with the IPU website, IPU News 
(the weekly eNewsletter) and the IPU’s 
social media channels all seeing a significant 
increase in engagement by members. The 
monthly GM is sent to members by email 
and post. Regular communications are 
sent to keep members up-to-date with 
vital current information to run an efficient 
pharmacy.
•  Advertising Campaigns:
 In 2018, the IPU updated its tagline across 
all advertising and social media campaigns 
to Think Pharmacy, to encourage members 
of the public to make pharmacy their first 
port of call for their healthcare needs and 
policy-makers to consider pharmacy as a 
location for new healthcare services. New 
TV and radio ads were developed for the 
2018 advertising campaign, which consisted 
of three segments: a Hay Fever campaign, 
which consisted of a radio ad; a Think 
Pharmacy campaign, which consisted of 
a TV and radio ad; and a Flu Vaccination 
campaign, which also consisted of a TV and 
radio ad. The ads were themed with our new 
Think Pharmacy tagline and were broadcast 
at different stages throughout the year. 
 The radio ads received extensive airplay 
across national and regional stations and 
our TV ads were also well-received across 









meetings with the 
PCRS to resolve 
outstanding issues
500+





on behalf of IPU 
members
612,000





 The IPU Review, IPU Yearbook & Diary and 
Annual Report are all produced in-house.
• Annual Review: 
 The Annual Review of the Sector is part of 
an ongoing annual series that authoritatively 
tracks changes in the economic and 
financial circumstances of community 
pharmacy. It enables us, as a representative 
body, to promote members’ interests 
based on credible facts that are measured 
consistently over time. The 2016/17 review 
was carried out by Fitzgerald Power.
• Submissions: 
 The IPU makes submissions on behalf of 
members on a range of issues. A list of 
submissions is available in Appendix I of the 
full Annual Report published on www.ipu.ie
• Market Research:
 The IPU commissioned market research 
amongst the general public on their 
pharmacy usage and attitudes towards 
pharmacy.
IPU National Pharmacy Conference
The annual IPU National Pharmacy Conference has been a great success since the inaugural event 
in 2011. Since then, the conference has grown and expanded to facilitate the needs of members. 
The conference is a great opportunity for members to come together in an educational and social 
environment and provides valuable networking opportunities for pharmacists. Over the weekend, 
pharmacists have the opportunity to build on their continuing professional development (CPD) 
and receive updates on the work of the IPU at the AGM. The President’s Dinner & Ball is also held 
over the weekend of the conference.
7. PHARMACY SERVICES
The Director of Pharmacy Services, 
Pamela Logan, coordinates all 
Professional, IT and Training matters within 
the IPU. Pamela acts as Secretary to the CPC 
and details of issues covered by this Committee 
can be found in the CPC report. She works 
with relevant departments and agencies, both 
nationally and internationally, to promote the 
role of the pharmacist. Pamela also represents 
the IPU at PGEU and FIP.
Liz Hoctor is the Professional Development 
and Learning Manager and continues to drive 
and enhance IPU Academy. IPU Academy 
has gone from strength to strength in 2018, 
providing members with access to high-quality 
learning opportunities and offering them 
support and assistance in complying with their 
obligations under the regime of mandatory 
continuing professional development. 
Liz also oversees IPUnet, the online web-based 
platform designed to support the delivery of 
pharmacy services, and represents the IPU 
on the Irish Institute of Pharmacy Advisory 
Group. Alma Barr and Sarahjane McCreery, 
Education Coordinators, help Liz with running 
IPU Academy.
Alan Reilly is our Head of Information & 
Technology, responsible for the development 
and implementation of the IPU’s ICT strategy 
including EU regulations such as data 
protection and medicines authentication. Alan 
is also responsible for identifying current and 
forthcoming IT opportunities, investigating 
how technology will facilitate future activities, 
participating in the national eHealth agenda, 
and advocating the IPU’s technological 
standpoint by liaising on behalf of the IPU 
with bodies such as Department of Health, 
Sláintecare, HIQA, eHealth Ireland, HSE, 
Healthlink, GPIT and others.
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8. TRAINING  
& HR DEPARTMENT 
Susan McManus, Training & HR 
Manager, organises and coordinates a selection 
of training courses for pharmacy staff. Janice 
Burke assists Susan in this department. 115 
Pharmacy Technicians graduated on 11 March. 
There are 230 students at present participating 
in Year 1 and 190 students in Year 2 of the 
course. In addition, 531 attended continuing 
professional development (CPD) for qualified 
pharmacy technicians in 2018. 180 students 
completed the Medicines Counter Assistant 
(MCA) Course in 2018 in eight venues around 
the country and 19 students completed 
the Medicines Counter Assistant (MCA) 
Refresher Course. 135 students completed 
the Interact course. The seventh cohort in 
the Diploma in Leadership and Management 
commenced in September 2018, with 12 
enrolments, while 29 students completed the 
Supervisory Development Course in 2018. We 
also continue to offer a Pharmacy Retail Sales 
course and the ‘Medicines in Care Homes’ 
training package and two new courses were 
added to the training programme in 2018: 
Basics in Health and Nutrition (12 enrolments) 
and Introduction to Employment Law and 
Employment Rights (13 enrolments).
The Dublin and Dun Laoghaire Education 
and Training Board (DDLETB) Pharmacy 
Sales Traineeship course was administered in 
a number of educational institutes and senior 
colleges around the country.
Susan also acts as Secretary to the Employee 
Pharmacists’ Committee (EPC), co-produces 
the IPU Yearbook and Diary and Wall-Planner, 
and advises members on human resource issues.
Darragh O’Loughlin accepting the IPU Excellence in Business award in the category of Community 
Based Training Programmes, by the Public Sector Awards. The awards are made to companies or 
organisations which are deemed to “demonstrate outstanding service, continuity, track record and 
general excellence in business to the public sector, Irish companies, and to the people of Ireland”.
Catherine Durran, Boots, 
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9. BUSINESS SERVICES 
The Business Development Manager, 
Darren Kelly, is responsible for retail 
business services and retail advice to 
members, along with Jim Curran. Darren and 
Jim represent IPU members on a number of 
strategic retail forums that have enabled us to 
provide a platform for a structured engagement 
between the retail sector and relevant 
Government departments and agencies on 
areas such as crime prevention, Brexit, upward-
only rent issues, town centre issues, retail and 
digital training. As part of the IPU Business 
Strategy to assist members in engaging with 
digital marketing and social media to enhance 
their business offering, we ran a number of 
training programmes for pharmacies in 2018. 
The workshops were fully attended and 
feedback was extremely positive. We also 
ran a number of Sales & Merchandising and 
Customer Service training programmes around 
the country in 2018. All sessions were full and 
feedback from attendees was very positive.
Members are kept up-to-date with 
current legislation through notices in IPU 
communications. The business Tip of the Week 
has proven to be very popular with members 
and serves to highlight all services available 
within the IPU. A number of affinity schemes 
have been negotiated for members on a range 
of products and services; details are carried on 
the IPU website.
Pictured at the IPU business briefing, which was held in Citywest Hotel on 26 June. Daragh Connolly, IPU; 
Larry Ryan, Behaviour & Attitudes; Dr Loraine Nolan, HPRA; Darragh O’Loughlin, IPU; Jason Bradshaw, 
JPA Brenson Lawlor; and Conall Ó’Móráin.
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Darren operates the IPU Retail Review Consultancy Service, which is available to members at a 
discounted rate. Over 120 pharmacies have availed of this service to date. Darren visits pharmacies for 
a full-day retail review, develops a retail plan and implements the plan over the course of the day. The 
feedback from members who have availed of this service has been very positive. Members can contact 
the Business Department for advice and information on the Business Helpline at 01 406 1558.
Darren also oversees the general maintenance and upkeep of Butterfield House.
Joyce Mulpeter, our Member Relationship Manager, visited over 700 pharmacies this year. Joyce has 
also been working to highlight the Pharmacy Watch system from hmR to ensure that members can get 
the maximum information from the system to assist them in their business.
10. EXTERNAL CONSULTANTS
MKC Communications (PR Consultants); Coolamber (IT Consultants); John Behan (Industrial Relations 
and Strategy Advisor) and Sean McHugh (Industrial Relations Advisor) provide advice and support to  
the IPU as requested on an ongoing basis. Leaf Environmental has been retained as consultants to the 
IPU on matters regarding environmental and waste management issues. Legal advice is provided by  
DAC Beachcroft on an ongoing basis and by Beauchamps solicitors in relation to specific matters.
11. MAIN COMMITTEE MEETINGS
The number of committee meetings was:
‘18 ’17 ‘16 ‘15 ‘14 ‘13
Executive Committee 6 5 5 7 7 5
Community Pharmacy Committee 3 3 4 5 4 4
Pharmacy Contractors’ Committee 4 5 4 6 2 3
Employee Pharmacists’ Committee 2 3 3 3 5 4
Finance Sub Committee 6 6 6 5 6 5
All Committee Meetings 0 0 0 0 0 1
12. CONCLUSION
The Pharmacy Watch service launched by Health Market Research (hmR) in 2014 has been adopted 
by more than 1,250 pharmacies and is delivering accurate and up-to-date information and best-in-
class benchmarking and trend reports to participating members. It also provides the IPU with essential 
information and analysis on the evolving state of the overall pharmaceutical market and the impact 
of ongoing reimbursement changes, which allows for more effective engagement with Government, 
the HSE and the media, and proved particularly important in the submission made to the Assessment 
of Pharmacy Fees carried out for the HSE as well as providing essential data to support proposals 
to Government for enhanced pharmacy services and identification of margin opportunities for 
participating pharmacies. I would encourage all of you to participate, as the benefits to all of us increase 
with the number of participants, and the purpose of the project is solely to benefit IPU members.
As Secretary General, I am lucky to work with a great team in Butterfield House, who are fully united 
in their determination to represent and serve the community pharmacy profession to the best of 
their ability. We will continue to innovate in order to effectively assist our members in ever-changing 
circumstances, while working ceaselessly to represent, advocate for and defend the community 
pharmacy sector and individual pharmacists, and promote the valuable work that pharmacists do every 
day in every town, village and community in the country. We are grateful for the incredible support 
we get from our members, without which we could not function, and are incredibly proud to represent 




Helen Deely, Programme Lead of the HSE SHCPP; Darragh O’Loughlin, 
Secretary General, IPU; Gráinne O’Leary, Pharmacist and member of IPU 
PCC; and Minister for Health Simon Harris TD.
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PHARMACY  
CONTRACTORS’  
COMMITTEE (PCC)  
REPORT 2018-2019
The Pharmacy Contractors’ Committee (PCC) is chaired by Eoghan Hanly, with Gráinne O’Leary 
as Vice-Chairperson. The Committee held four meetings in 2018 and two meetings so far in 2019. 
Two further meetings are scheduled for this year. The PCC’s mission statement is:
Advocating and negotiating on behalf of community 
pharmacy contractors with government and its agencies 
to secure fair remuneration and equitable contractual 
terms for the delivery of services to patients.
18
EXECUTIVE SUMMARY
The role of the PCC is to:
•  Devise a strategy to ensure the Committee 
delivers on the IPU’s priorities and strategic 
position;
•  Negotiate with the Department of Health 
and the HSE on policy issues relating to 
pharmacy and on all issues relating to 
remuneration;
•  Deal with matters relating to the contract 
and the community drug schemes;
•  Provide leadership, information and advice 
to members to ensure they are claiming 
correctly for all medicines supplied and 
services provided under the contract; and
•  Ensure that changes to the administration 
of the community drug schemes do not 
disadvantage members and that they are 
kept informed of such changes.
Over the past 12 months, the PCC has dealt 
with a variety of issues and has progressed a 
number of different items on behalf of the 
contractor members of the IPU. The following is 
a summary of some of the key issues dealt with 
since the last AGM.
FEMPI
In June 2018, a Submission was made to 
the Minister for Health demanding the 
unwinding of FEMPI for pharmacists. In the 
Submission, we pointed out that pharmacists 
have cooperated with a range of HSE audit 
and validation measures, which have come at 
a significant cost to pharmacies while being 
of no benefit to pharmacists or patients. The 
Submission demonstrated the urgent need to 
reverse cuts made under FEMPI and put in 
place a viable and realistic payment model that 
provides a sustainable dispensing fee across all 
schemes and that pharmacy dispensing fees 
must be increased at a minimum to the levels 
recommended by the Independent Body on 
Pharmacy Contract Pricing in 2008.
In December, we met with Department 
of Health Officials and again, outlining 
pharmacists’ deep frustration at the 
unreasonable failure to commence the 
unwinding of FEMPI cuts and said that the 
ongoing decline in pharmacy revenues was 
causing significant financial strain in the sector, 
particularly in light of upward pressure on all 
costs. We demanded to know exactly when the 
long-promised exit pathway from FEMPI for 
pharmacists would begin. 
The Department of Health explained that they 
would be engaging with representatives of each 
of the contracted healthcare professions under 
the new legislation (Section 42 of the Public 
Service Pay and Pensions Act 2017) to set out 
an exit pathway from FEMPI and introduce 
new fee schedules/contracts before the end of 
2019. They reported that the Department of 
Health was currently engaging with GPs and 
did not have the capacity to engage with two 
professions in parallel.
In response to our demands to know where the 
€2.5 million originally promised to pharmacy 
in 2016 had gone, the Department of Health 
confirmed that it was still in the base funding, as 
there had been no agreement on how it could 
be distributed or allocated. The Department 
of Health confirmed that while the financial 
space in primary care is tight, money will be 
forthcoming for new primary care services 
in line with Sláintecare which improve health 
outcomes and provide value for money and 
benefits for patients.
There were also a number of other meetings 
with key politicians and opposition health 
spokespersons to set out our position and gain 
support on advancing our agenda.
PCRS Pharmacy Interface Project
The purpose of this project is to enhance 
the electronic interface between pharmacy 
contractors and the PCRS. The first deliverables 
of this project – electronic submission of 
Dental, EU claims, managing owings and 
enhanced XML listing – were initially due to 
be rolled out last year but, following a dispute 
between the IPU and the HSE, this did not 
happen.
We advised the HSE PCRS in February 2018 
that our suspension of cooperation on the 
implementation of this project was due to an 
accumulation over time of numerous factors, 
including the failure of the Department of 
Health to stick to previous commitments to 
commence the unwinding of FEMPI cuts to 
pharmacy fees, the endless deluge of circulars 
and the increased administrative burden being 
placed upon contractors. Following a number 
of meetings towards the end of 2018, the 
Committees decided to re-engage with the 
PCRS on foot of a formal acknowledgement of 
our role in patient care and our expertise in the 
use of medicines and supporting patients, as well 
as commitments on new services and a desire to 
improve our relationship with the Department 
in order to make progress on contractual reform 
and discussions on fees.
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In conjunction with the previously agreed 
project, the HSE PCRS has also agreed that 
we would work jointly with them to review the 
operation and administration of the States 
Community Drug schemes with a view to 
improving their efficiency, by streamlining 
and reducing the administrative burden on 
both the PCRS and community pharmacies 
and by moving as much paperwork as possible 
online. We have sought the release of funds 
from the Department of Health to support full 
implementation of Medicines Authentication 
and the Interface Project.
Joint Consultative Group
The purpose of the Joint Consultative Group 
(JCG) is to allow direct liaison, discussions, 
consultation and negotiations between 
senior representatives of the IPU and PCRS, 
with the objective of seeking agreement on 
matters pertaining to the administration 
of the Community Drug Schemes and 
associated remuneration and reimbursement of 
pharmacists. The JCG has met on six occasions 
in the past 12 months.
We addressed many issues on behalf of IPU 
members through the auspices of the JCG. 
These include ongoing reviews in relation to 
phased dispensing and the Incomplete Claims 
Protocol. We sought to mitigate and advocate 
on behalf of all members in relation to a wide 
range of items including, phased dispensing, 
Incomplete Claims Protocol, centralisation of 
DPS, High Tech Ordering Hub and probity 
issues.
We continue to highlight, through this forum, 
the increased burden being placed on pharmacy 
contractors by the HSE PCRS through 
excessive administrative arrangements and ever 
more onerous audit and probity.
Monitored Dosage System
Salutem Insights completed a study in 
early 2018 on behalf of the IPU on the 
‘Implementation of a Monitored Dosage 
System (MDS) to improve Non–Adherence in 
Ambulatory Elderly Patients on polypharmacy 
in the Irish Healthcare System’. A Submission 
was made to the Department of Health and the 
HSE for a specific fee to be paid to pharmacists 
for providing an MDS service.
Joint Operational Group
The work of the Joint Operational Group 
(JOG) involves arrangements for processing 
payment of claims and resolving claim-related 
queries/issues raised by individual community 
pharmacy contractors and other operational /
administrative arrangements. The JOG met six 
times in the past year. This forum has proved 
beneficial in resolving the majority of issues 
raised on behalf of members.
We engaged with the HSE PCRS and 
nominated pharmacists to sit on investigation 
Committees under the Community Pharmacy 
Contractor Agreement, providing them with 
specific legal training, support and advice.
There has been an increase in the number of 
claims investigations and we provided assistance 
to members in responding to letters received 
from the HSE PCRS. We accompanied 
several individual pharmacists to meetings with 
the HSE PCRS to assist them in resolving 
outstanding issues achieving substantially 
favourable outcomes for all affected members.
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The Community Pharmacy Committee (CPC) is chaired by Elizabeth Lang, with Jonathon 
Morrissey as Vice-Chair. CPC’s mission statement is:
CPC – working to serve and support community 
pharmacists in their practices and to promote and 
expand their role as pharmacists by continually 
developing professional, ethical, business and 
technological ideals and standards.
CPC is split into three sub-groups:
Professional Steering Group
Anna Kelly, Jonathon Morrissey, Sheila O’Loughlin, Brendan Quinn, Daragh Quinn, Clare 
Fitzell.
Business Steering Group
Mary Barry, Louise Begley, Pat Dalton, Roy Hogan, David Gormley, Paul Kenny (Aidan Walsh 
resigned in February 2019).
IT Steering Group
Tom Concannon, Noel Stenson. Ann Marie Horan (Exec) and Dan Burns (PCC) have been co-
opted onto ITSG along with Jack Shanahan, David 
Reen, Joseph Haire and Ciaran Mulligan.
CPC has met three times since the 2018 
AGM (May and October 2018 and February 
2019), dealing with a wide variety of issues. 
The following is a summary of the key issues 
dealt with over the last 12 months under the 
headings outlined in the CPC Strategy 
2018 – 2020 which was developed by 
CPC in May 2018.
COMMUNITY PHARMACY 
COMMITTEE (CPC)
REPORT 2018 – 2019
Daragh Connolly, IPU President,  
with Minister for Health, Simon Harris TD
EXECUTIVE SUMMARY
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Darragh O’Loughlin, Secretary General, with 
the Minister for Health, Simon Harris TD, at the 
launch of the IPU and HSE Sexual Health and 
Crisis Pregnancy Programme (SHCPP) national 
public awareness campaign.
PROFESSIONAL ISSUES
Promote the Role of the Pharmacist  
in Government and HSE Strategy
We met with the Executive Director 
of Sláintecare in October 2018 to put 
the network of community pharmacies 
throughout Ireland at their disposal to help 
them deliver convenient, accessible, high 
quality healthcare in every town, village and 
community in the country. We outlined the 
details of our proposals for a Minor Ailment 
Scheme, New Medicine Service and Access 
to Contraception. We presented a Proposal 
for a Community Pharmacy-Based Triage 
Programme to the Executive Director of 
Sláintecare in March 2019, outlining the triage 
services that could be offered in a community 
pharmacy: responding to symptoms (minor 
ailment scheme); emergency medicines 
administration; and minor injury management.
We had an official meeting with the 
Department of Health in December 2018 to 
discuss a number of the proposals that we have 
made over the past few years in relation to 
enhanced pharmacy services: Minor Ailment 
Scheme, Access to Contraception, NMS, MUR 
and broadening existing Vaccination services. 
At a meeting with the National Immunisation 
Office in March 2019, it was confirmed that 
it was now Department of Health policy that 
a HSE-reimbursed pharmacy pneumococcal 
vaccination service be introduced. The HSE is 
working to make this happen by October 2019.
Develop Services Frameworks for  
innovative pharmacy services
We are part of the HSE Working Group to 
establish treatment of patients with Hepatitis 
C in community settings. The first meeting 
took place in January 2019 and it is intended 
to start rolling out the service in May 2019 to 
methadone patients.
In addition to the initial Pharmacycare 
services of a sharps service for injectable 
devices for Pfizer (Enbrel), Roche 
(RoActemra), Novo Nordisk (Norditropin) 
and Biogen (Benepali), NordicPharma 
launched the first patient education service 
for Nordimet in October 2018.
To help pharmacies who provide an injection 
administration service to patients, we  
produced an SOP for the intramuscular 
injection of NeoCytamen and an SOP for  
the subcutaneous injection of Prolia.
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Engage with HSE Clinical Care Programmes 
to consolidate the pharmacist’s role in chronic 
disease management
The IPU Pilot to Detect Hypertension and 
Atrial Fibrillation in the Community was carried 
out in 2018 in 68 community pharmacies and 
1,194 people were checked in a two-month 
period. The aim was to identify those people 
50 years of age and over who were at risk 
of hypertension or atrial fibrillation or both. 
An irregular pulse (possible atrial fibrillation) 
was detected in 5.5% of participants who 
were checked; 27% of participants were 
identified with high blood pressure (possible 
hypertension); both an irregular pulse 
(possible atrial fibrillation) and high blood 
pressure (possible hypertension) were noted 
in 2% of participants; 26% of all participants 
checked were referred to their GP; overall, 
83% of participants were happy with the 
information they were given by the pharmacist 
who undertook the health check and 91% of 
participants said they were more aware of 
blood pressure and atrial fibrillation as a result 
of taking part in the pilot. The pilot report was 
launched in December 2018. We met with the 
HSE in March 2019 to discuss the roll-out of 
the service nationally.
We have a seat on Clinical Care Programmes 
for Respiratory Conditions, Sexual Health 
and Healthcare Acquired Infection and 
have facilitated community pharmacists on 
Rheumatology and Disability.
Pictured at the Pharmacycare launch of the Nordimet patient education service, L-R: 
Pamela Logan, Director of Pharmacy Services, IPU; Olive Kelly, Key Account Manager 
Nordic Pharma; Guen Kelly, Marketing Manager, Nordic Pharma; and Alan Moran, 
Group Managing Director, Hibernian Healthcare.
Develop strategies to facilitate pharmacist 
prescribing within the community practice 
setting
We met with the National Women’s Council 
of Ireland (NWCI) in August 2018 and the 
HSE Sexual Health and Crisis Pregnancy 
Programme in September 2018 to ask for 
their support for our Access to Contraception 
proposal. The Department of Health has set up 
a Working Group on Access to Contraception; 
we wrote to the Minister in February 2019, 
asking to be included on the Group. At an 
informal meeting with the Minister in March 
2019, he confirmed that no representative 
bodies would be on the Group, but the Group 
would certainly consider the IPU proposal.
A pharmacy-only version of sumatriptan was 
launched in October 2018.
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IT
Maintain the IPU Product File as the definitive 
file on the Irish market for medicines and 
medical devices
We are working with the vendors on ICT 
developments for pharmacy and Web Service 
Distribution of the IPU Product File. Virtual 
Medicinal Product (VMP) classification 
is now complete and is available via Web 
Service Distribution. Piloting has begun on 
Web Service Distribution and it is hoped to 
have a Web Service Distribution in place 
by September 2019. A web portal has been 
developed and is currently being tested; this 
portal will allow manufacturers, suppliers and 
other licence holders to submit updates to the 
IPU Product File. Work has commenced on 
creating Virtual Therapeutic Moiety (VTM) 
concepts in the IPU Product File. SNOMED 
mapping is complete on the IPU Product File 
for Dose Form and Route of Administration 
and the process of mapping to Substance has 
commenced, as an initial step towards the goal 
of healthcare systems interoperability and 
we are now mapping this to EDQM. We are 
working with SNOMED Ireland to include IPU 
Product File information in the first official 
SNOMED CT file for Ireland in April 2019. 
The IPU Product File continues to adhere to 
ISO standards and requirements, with on-going 
internal and external audits.
Promote the adoption of the IPU Product File 
as the HSE/eHealth Ireland National Medicinal 
Product Catalogue (NMPC) 
In January 2018, we made an offer to the 
HSE’s Head of the Programme for Health 
Service Improvement to collaborate with the 
HSE and eHealth Ireland in the delivery of a 
high quality information service that will help to 
integrate the Irish health service and improve 
stakeholder access to medicinal information, 
namely the use of the IPU Product File as 
a main information source for the National 
Medicinal Product Catalogue. In June 2018, 
we forwarded the proposal to the Chief 
Information Officer (CIO) for the HSE and we 
met with him in July 2018 to further discuss 
the proposal. In February 2019, we brought the 
proposal to the attention of Sláintecare and the 
Head of eHealth in the Department of Health.
Continue to work with HIQA on the eHealth 
Standards Advisory Group (eSAG) and the 
development of pharmacy-related standards
In 2018, HIQA completed a revision of 
their International Review of ePrescribing. 
HIQA has a remit to provide advice and make 
recommendations to the Minister. In March 
2018, the IPU joined an Advisory Group on 
ePrescribing; the purpose of the group was to 
bring together the key stakeholders in this area. 
Sinead McCool, Pilot Project Manager, Dr Declan O’Callaghan, Medical Director, Pfizer, 
Dr Angie Brown, Consultant Cardiologist and Medical Director, Irish Heart Foundation and 
Daragh Connolly, President of the Irish Pharmacy Union.
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Taking into account the evidence from 
HIQA’s international review and advice 
from its members, the Group developed 
recommendations relating to the governance 
and implementation of a national ePrescribing 
solution for Ireland and HIQA published the 
recommendations in October 2019.
In July 2018, members from the CPC ITSG 
and wider membership, represented the IPU on 
a HIQA working group revising its data model 
specification for ePrescribing and dispensing 
records. In September 2018, we participated in 
HIQA’s eSAG working group on an Electronic 
Patient Summary Standard.
Work with all relevant stakeholders to deliver a 
national Primary Care ePrescribing System
In April 2018, we produced the IPU 
ePrescribing Specification for Community 
Pharmacy, a high-level specification of 
functional requirements to cover all dispensing 
scenarios in Irish pharmacies and the ideal 
technical solution necessary to support them. 
We held a public and targeted consultation 
to give all interested parties an opportunity 
to provide their feedback on this draft 
specification. The completed specification was 
published in October 2018 and made available 
to the Department of Health, the HSE, 
eHealth Ireland, Healthlink, HIQA and other 
stakeholders involved in delivering a national 
ePrescribing solution. In February and March 
2019, we met with Sláintecare and the Head
eHealth from the Department of Health to 
prioritise ePrescribing as a national project.
Work with all relevant stakeholders to deliver a 
national Shared Care Record which will inform 
the Electronic Health Record
As well as participating in HIQA’s eSAG 
Working Group on an Electronic Patient 
Summary Standard (September 2018), the 
delivery of a national Summary Care record 
was discussed at the Sláintecare meetings in 
February and March 2019.
Work with the Department of Health and 
system vendors on the standardisation of 
dispensary systems with the aim of getting 
certification to comply with pharmacy 
regulations and ePrescribing standards
There is a legal requirement to have computer 
software independently validated and certified 
as set out in the Regulation of Retail Pharmacy 
Businesses Regulations. To that end, we 
produced and published the IPU Standard 
Dispensary System Specification in October 
2018 to help the Department of Health with 
the certification process. In March 2019, 
the Department of Health engaged with 
stakeholders, including the system vendors, to 
progress with certification.
Left to right: Ciaran Mulligan MPSI (Moore’s 
Pharmacy, Crumlin), David Doyle (IMVO),
Robert Antal (IMVO), Alan Reilly (IPU),  
Leonie Clarke MPSI (IMVO).
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Work with wholesalers and vendors to use 
the Pharmacy Internet Messaging Standards 
(PIMS) to facilitate real-time ecommerce 
ordering solutions directly from  
dispensary software
The HSE PCRS has developed a High Tech 
Medicines Ordering and Monitoring Hub. The 
PIMS protocol is being used in the central 
online system which interfaces between 
pharmacies and wholesalers.
Continue to work with the Irish Medicines 
Verification Organisation (IMVO) and all 
relevant stakeholders to implement medicines 
authentication in Ireland
Robert Antal (IMVO), Alan Reilly (IPU), 
Leonie Clarke MPSI (IMVO).
Throughout 2018, we ran monthly articles in 
the IPU Review on Medicines Authentication 
and the implications of the EU Delegated 
Regulation for community pharmacy, as well 
as weekly items in the IPU eNewsletter. We 
produced an FAQ, reports and a checklist to 
assist members in preparing their pharmacy 
for the new law. We sent a 2D barcode reader 
to every pharmacy member in November 
2018, as well as a letter advising members 
on the necessary steps and in December 
2018 we presented a webinar on Medicines 
Authentication, explaining the principles 
of the EU delegated regulation. In the run 
up to the 9 February 2019 deadline, we 
raised concerns around manufacturers’ and 
other stakeholders’ readiness and we agreed 
an implementation plan with IMVO, the 
Department of Health, the PSI and the 
HPRA, where it was decided that the offences 
and penalties in the associated Statutory 
Instrument would not come into force until 
the whole system is stable.
Assess and prioritise pharmacy IT 
requirements and influence the development 
roadmap for dispensary system developments 
through system vendors and other providers of 
pharmacy software
Throughout 2018 and 2019, we met with 
the pharmacy system vendors to discuss ICT 
developments for pharmacy, PCRS circulars 
and developments in the IPU Product File.
BUSINESS
Business Policy
The Director of Communications & Strategy 
sits on the Retail Consultation Forum. Their 
pre-Budget 2019 Submission included a 
specific section on pharmacy-related issues 
including PSI fees, DUMP, Prescription 
Levy and Black Market activities. As part 
of the Retail Consultation Forum, we are 
involved in the Retail Digital Skills Working 
Group. This Group is now primarily looking 
at ways of making retail training available 
to staff who want to earn as they learn. This 
group met three times in 2018. The Director 
of Communications & Strategy made a 
presentation to the Retail Consultation 
Forum and the Minister for Jobs regarding 
the impact of Brexit on the pharmacy sector.
We are also involved in the development of 
a Retail Apprenticeship with Retail Ireland 
Skillnet. This will take around 18 months of 
development but is progressing positively at 
the moment.
We have a number of pharmacies who have 
been summoned to appear in court regarding 
IMRO/PPI fees. We are awaiting the 
outcome of a possible test case based  
on the defence supplied by our legal  
team on the matter.
The Business Development Manager attends 
meetings of the National Forum on Retail 
Crime. The latest Garda analysis figures  
were delivered at the Forum meetings  
which identified that crimes against 
pharmacy were still higher than the retail 
average, with cosmetics being the most 
frequent item stolen.
In August 2018, the Director of 
Communications and Strategy, the Press and 
Communications Manager and the Business 
Development Manager met with members of 
IPHA to set up the Self Care Working Group 
to further the Self Care project.
Business Support & Training
14 Retail Reviews were carried out over the 
course of 2018. Eight Retail Consultations 
were also carried out and should lead to full 
reviews in 2019. Two Retail Reviews have 
been carried out so far in 2019.
Our Member Relationship Manager visited 
over 550 pharmacies in 2018 outlining IPU 
services and benefits for members. hmR 








Visits to pharmacies 
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We ran a number of training programmes 
in 2018 in Digital Marketing, Retail Sales 
and Customer Services. The Diploma in 
Leadership & Management started again in 
September 2018 with another 12 students 
enrolled on the programme. Basics in 
Nutrition was a new course on offer in 2018 
and we had 15 attendees in September 
2018 and 18 attendees in January 2019. The 
Business Development Manager is working 
with Retail Ireland to develop a Retail 
Apprenticeship which will have a pharmacy 
retail module. The Business Development 
Manager completed a QQI Level 6 Manual 
Handling Instructor Course in November 
2018 with a distinction. We will deliver this 
course to members in 2019.
Business Department Marketing 
Tip of the Week in the eNewsletter 
has proven to be very popular since we 
introduced it in 2018 with all departments 
now using this initiative to highlight services 
available to members.
In June 2018, the Business Team hosted a 
Business event in conjunction with Davys and 
JPA Brenson Lawlor in the Citywest Hotel 
entitled “Pharmacy – What does the future 
hold?”. Over 120 people attended this event.
Business Intelligence 
The B&A Pharmacy Usage & Attitudes 
Survey results were released to members in 
June 2018.
The Annual Review of the Sector 2016 
– 2017 was completed and released to 
members in June 2018.
The Annual Crime Survey was sent to 
members in January 2019.
The Member Relationship Manager is 
assisting members who are signed up to hmR 
and also working with hmR Ireland on the 
recruitment of pharmacies who have not 
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The Employee Pharmacists’ Committee (EPC) represents the interests of community 
pharmacy employee members of the IPU. The EPC is chaired by Sinéad Ryan, who took 
over from Sheila O’Loughlin in February 2018, with Claire Fitzell as Vice-Chair, succeeding 
Elaine Clarke. Currently, there are 1,436 community employee members of the IPU, which 
comprises 63% of the full membership. The mission statement of the EPC is:
To promote the professional and economic interests of 
employee pharmacists and constructively engage with 
other Committees of the IPU and other stakeholders 
through the Employee Pharmacists’ Committee.
The EPC met twice since the 2018 AGM 
(June and November 2018). The EPC 
continues to have active representation on 
other IPU Committees, with three employee 
representatives on the Executive Committee 
and four representatives on the Community 
Pharmacy Committee. This representation 
guarantees that the views of employee 
pharmacists are voiced and heard on the 
other Committees of the IPU, therefore 
empowering employee input into decisions 
and in the development and implementation 
of IPU policies.
Communications
The redesign of the IPU website has 
facilitated the development of the ‘Employee 
Pharmacists’ section of the site. Useful 
resources can be easily accessed by employee 
members and the EPC’s objective is to 
continue to develop this online forum.
At the June 2018 EPC meeting, the 
Committee agreed to continue to promote 
the interests of employee pharmacists 
through IPU Review articles. The EPC’s 
article published in the July 2018 issue on 
‘How will you manage?’ drew attention to the 
pharmacist’s role which includes managing 
and leading the pharmacy team through the 
ability to delegate and motivate. The article 
highlighted the IPU/ILM Diploma
in Leadership and Management two-year 
course that has been delivered in-house 
from 2013 supported by testimonials from 
Diploma graduates.
Events
In 2018, the Committee agreed to have 
an EPC representative attend the Clarity 
Locum Evening at the end of the year. The 
main objectives of attending were to engage 
with newly qualified pharmacists and to 
outline the benefits of IPU membership. 
Sinéad Ryan, made a presentation to 
pharmacists at this event on 20 November 
2018; 45 new graduates signed-up to IPU 
membership.
Recruitment and Retention
The EPC liaised with Larry Ryan, Behaviour 
& Attitudes, to carry out research on the 
recruitment and retention of pharmacists. 
In conjunction with other Committees, 
the EPC was interested to gain insight 
into why people become pharmacists and 
what influences their career path, most 
specifically, in terms of pharmacists’ interest 
in community pharmacy. This research has 
proved to be very important and the results 
of this survey has been communicated to the 
PSI and it has been reported on in national 
media including RTÉ and the journal.ie.
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Student Pharmacists
The IPU was delighted to support student 
pharmacists with their successful campaign 
during the year and the EPC is looking for 
ways to engage with student pharmacists 
moving forward.
Representation and Services
The EPC will continue to pursue its 
objectives with intent and to actively 
represent the interests of employee 
members. It will also ensure that the IPU 
continues to provide services and support to 
employee members within the community 
pharmacy sector. The coming years will be 
trying for community pharmacy; therefore, 
it is vital that employee pharmacists have a 
representative body which supports them 
and advocates on their behalf. The EPC will 
continue to be this body and it recommends 
the involvement of more employees, on both 
a regional and national platform within the 
IPU, in order to strengthen the resolve of 
employee pharmacists, both in the IPU and 
throughout the profession.
Conclusion
The EPC urges employee members to 
use their membership to the full and keep 
themselves well-versed by reading the IPU 
weekly eNewsletter, General Memoranda, 
IPU Review and other information provided 
by the IPU. In June 2010, all IPU members 
were assigned an @ipumail.ie email account 
and the EPC continually reminds employee 
members who have not activated their 
account to do so without delay. The EPC 
would also recommend that employee 
members check the ‘Employee Pharmacists’ 






1. The Pharmaceutical Group of the European 
Union (PGEU) is the European association 
representing community pharmacists in 32 
European countries including EU Member 
States, EEA countries and EU applicant 
countries. Overall, PGEU represents over 
400,000 community pharmacists in 
Europe through their professional bodies and 
pharmacists’ associations. PGEU’s objective 
is to promote the role of pharmacists as key 
players in healthcare systems throughout 
Europe and to ensure that the views of the 
pharmacy profession are taken into account in 
the EU decision-making process.
 The IPU is represented at PGEU by Darragh 
O’Loughlin, Head of Delegation, Daragh 
Connolly and Pamela Logan. We have been 
very active within PGEU over the past 
year, ensuring that community pharmacy is 
considered in a wide variety of EU Directives 
and Regulations. 70% of legislation in Ireland 
comes from EU Directives and Regulations 
so it is vital that lobbying is done at this level 
rather than waiting for transposition into Irish 
legislation.
2. The International Pharmaceutical 
Federation (FIP) is the global federation 
of national associations of pharmacists and 
pharmaceutical scientists and is a non-
governmental organisation in official relations 
with the World Health Organisation. With 
144 member organisations, FIP represents 
over four million experts in medicines, 
supporting the responsible use of medicines 
around the world. FIP’s mission is to “improve 
global health by supporting the advancement 
of pharmaceutical practice, sciences and 
education”.
 The 78th Annual World Congress of 
Pharmacy and Pharmaceutical Sciences was 
held in Glasgow from 2 to 6 September 2018. 
The Congress was hosted by the International 
Pharmaceutical Federation (FIP) in 
collaboration with the Royal Pharmaceutical 
Society (RPS) and saw 3,014 people 
registered from 108 countries
 The 79th Annual World Congress of 
Pharmacy and Pharmaceutical Sciences 
will be held in Abu Dhabi from 22 to 26 
September 2019.
3. The IPU also meets with the Presidents and 
the CEOs of Pharmintercom countries 
(Australia, Canada, Ireland, New Zealand, 
South Africa, UK, USA) on an annual basis.
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2019 AGM MOTIONS
The following motions, proposed in accordance with Article 30 of the IPU Constitution,  
are brought before the meeting for consideration:
1. Proposed: Jonathon Morrissey
 Seconded: Anna Kelly
 “That this AGM commends the Sláintecare Programme for engaging with the IPU to explore the 
healthcare role of the pharmacist and looks forward to the expansion of pharmacy services as part of 
reforming and modernising healthcare in Ireland.”
2. Proposed: John Mc Laughlin
 Seconded: Jack Shanahan
 “That this AGM calls on the HSE to pay for Blister Pack Dispensing in the following cases:
a. Hospital Discharge patients prescribed more than three drugs on discharge;
b. Psychiatric Patients; 
c. All Patients over 80 years of age; and
d. Any Patients that clearly present an identifiable risk of making errors in their medications.”
3. Proposed: Daragh Connolly
 Seconded: Sinéad Ryan
 “That this AGM calls for the introduction of a new category of IPU membership for pharmacy students.”
4. Proposed: Sheila O’ Loughlin
 Seconded: Sinéad Ryan
 “That this AGM calls on the HSE PCRS and the PSI to review and reduce the level of unnecessary 
bureaucracy they foist on community pharmacists which risks exacerbating the exodus of young 
pharmacists from the profession.”
5. Proposed: Anna Kelly
 Seconded: Denis O’ Driscoll
 “That this AGM calls on the Health Service Executive to discontinue the approval process for Direct Oral 
Anticoagulants (DOACs) as it is no longer relevant.”
6. Proposed: Eoghan Hanly
 Seconded: Michael Tierney
 “That this AGM calls upon the Minister for Health, following the recent agreement with General 
Practitioners, to immediately commence substantive talks with the IPU to reverse FEMPI as it applies  
to community pharmacy contractors.”
7. Proposed: Richard Collis
 Seconded: Edward MacManus
 “That this AGM calls on the IPU to create a dedicated unit, which would deal with all policy matters and 
issues emanating from the PSI. This unit would regularly update members through the IPU Review of 
any and all developments that affect the practice of pharmacy. It would lobby and articulate on issues of 
concern and interest to members such as, Inspection Policy, Fitness to Practice, CPD. It would act as a 
focus for members interacting with the PSI, enabling the IPU to be seen as safeguarding the interests of 
the general membership.”
7. Proposed: Daragh Connolly
 Seconded: Eoghan Hanly
 “That the IPU Constitution be amended by the insertion of a new article 4.n. and the amendment of 
the existing article 4.m. in order to provide an alternative method for collection of membership fees in 
circumstances where the Health Service Executive ceases to make deductions from the professional fees 
payable to members under the Community Pharmacy Contractor Agreement and to remit same to the 
Pharmacy Contractors’ Committee of the IPU.”
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1. Irish Pharmacy Union
Financial Reports and Accounts for  
Year Ended 31 December 2017
In accordance with the Constitution of the 
IPU, the Executive Committee submits 
the audited accounts for consideration by 
members. The full details of the accounts are 
available on the members’ area of www.ipu.ie.  
 
If the accounts are approved by the meeting, 
after their presentation, members will be asked 
to formally adopt the Accounts for the year 
ended 31 December 2017. In accordance with 
Article 26.b of the IPU Constitution, the 
Trustees have appointed JPA Brenson Lawlor 
as Auditors for the IPU and IPU Services Ltd. 
Members will be asked to agree the election of 
auditors. In this context, the following motions 
will be put to the meeting:  
 
a. “That the Executive Committee Report 
and Audited Statement of Accounts of the 
Irish Pharmacy Union for the year ended 
31 December 2017 as submitted to this 
meeting, be and hereby are adopted.”
 
b. “That this meeting agrees to the election of 
JPA Brenson Lawlor as Auditors for the IPU 
and IPU Services Ltd.”
2. IPU Services Limited
Financial Reports and Accounts for  
Year Ended 31 December 2017
At this Annual General Meeting of IPU Services 
Ltd, members are asked to consider the Directors’ 
Report and the Auditor’s Report on the Accounts 
for the Year Ended 31 December 2017. The full 
accounts and financial reports are available on the 
members’ area of www.ipu.ie. 
If the accounts are approved, members will be 
asked to resolve:  
“That the Directors’ Report and Audited 
Statement of Accounts for the year ended 31 
December 2017 as submitted to this meeting,  
be and are hereby adopted.”
 
FINANCIAL STATEMENTS 
FOR THE YEAR ENDED 31 DECEMBER 2018
1. Irish Pharmacy Union
Financial Reports and Accounts for Year Ended 31 December 2018
In accordance with the Constitution of the IPU, the Executive Committee submits the audited accounts for 
consideration by members. The full details of the accounts are available on the members’ area of www.ipu.ie.
If the accounts are approved by the meeting, after their presentation, members will be asked to formally adopt the 
Accounts for the year ended 31 December 2018. In accordance with Article 26.b of the IPU Constitution, the Trustees 
have appointed JPA Brenson Lawlor as Auditors for the IPU and IPU Services Ltd. Members will be asked to agree the 
election of auditors. In this context, the following motions will be put to the meeting:
a. “That the Executive Committee Report and Audited Statement of Accounts of the Irish Pharmacy Union for the year 
ended 31 December 2018 as submitted to this meeting, be and hereby are adopted.”
b. “That this meeting agrees to the election of JPA Brenson Lawlor as Auditors for the IPU and IPU Services Ltd.”
2. IPU Services Limited
Financial Reports and Accounts for Year Ended 31 December 2018
At this Annual General Meeting of IPU Services Ltd, members are asked to consider the Directors’ Report and the 
Auditor’s Report on the Accounts for the Year Ended 31 December 2018. The full accounts and financial reports are 
available on the members’ area of www.ipu.ie.
If the accounts are approved, members will be asked to resolve:
 “That the Directors’ Report and Audited Statement of Accounts for the year ended 31 December 2018 as submitted to 
this meeting, be and are hereby adopted.”
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Responsibilities of IPU’s Officers
The Irish Pharmacy Union’s (“IPU”) Officers are responsible for preparing the annual report 
and the financial statements in accordance with applicable Irish law and FRS 102 The Financial 
Reporting Standard applicable in the UK and Republic of Ireland (Generally Accepted 
Accounting Practice in Ireland) issued by the Financial Reporting Council.
The financial statements reflect the activities of the IPU, and do not include the financial affairs 
of regional committees.
The IPU’s Officers acknowledge their responsibility for ensuring that adequate financial controls 
are in place, and that competent financial management is employed. The IPU’s Officers also 
understand and concur with the major judgements and estimates which underlie the financial 
statements.
In accordance with current accounting practice and financial reporting standards it is 
recommended that the IPU’s Officers prepare financial statements for each financial year which 
give a true and fair view of the state of the affairs of the IPU as at the end of the year and of the 
profit or loss of the IPU for that year.
In preparing these financial statements, the IPU’s Officers are required to:
• select suitable accounting policies for the financial statements and then apply them 
consistently;
• make judgements and estimates that are reasonable and prudent; and
• prepare the financial statements on the going concern basis.
The IPU’s Officers are responsible for keeping adequate accounting records which correctly 
explain and record the transactions of the IPU, enable at any time the assets, liabilities, financial 
position, and profit or loss of the IPU to be determined with reasonable accuracy and to enable 
them to ensure that the financial statements comply with current accounting practice and 
financial reporting standards.  They are also responsible for safeguarding the assets of the IPU 
and hence for taking reasonable steps for the prevention and detection of fraud and other 
irregularities.
Review of the development activities and achievements of IPU during the year
The Irish Pharmacy Union adopted a new Statement of Strategy during 2017, Putting 
Community at the Centre of Primary Healthcare in Ireland, under which it has continued to 
promote the professional and economic interests of its members throughout the year.
Other Services / Supports
At 1 January 2018 the IPU had 2,225 members. During the year, 231 members joined and 130
members cancelled or let their membership lapse. At 31 December 2018 the IPU had 2,326 
members. 
The IPU provides members with;
• A National Voice: The IPU represents more than 95% of community pharmacies in Ireland. 
We negotiate on behalf of all Community Pharmacies with the HSE, Government and other 
bodies in relation to a variety of issues, including the Community Pharmacy Contractors 
Agreement;
• Exclusive access to IPU Product File, with details of approximately 55,000 products and 
regular updates on products which have been discontinued, are in short supply etc.;
• Professional advice and support in relation to practice guidelines, compliance and regulation;
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• Pharmacy and Retail Business advice and training for you and your employees;
• Up to date listing of Locum support available;
• Advice and support in relation to financial and employment issues;
• IPU website with members’ only area and on-line information which can be tailored to 
individual pharmacies;
• IPU Publications including weekly e-newsletter, monthly General Memorandum, the IPU 
Review and the IPU Yearbook and Diary;
• Detailed information and advice on all Community Drugs Schemes and individual support in 
resolving claim and payment issues with HSE PCRS, which is an area of increasing activity;
• IPU NET, a web-based application to support members in the delivering and recording of 
services to patients; and
• IPU Academy, an educational service to support members with their Continuing Professional 
Development, which is now mandatory for all pharmacists.
The IPU also provides a significant number of training courses and other business supports to 
help IPU members develop their professional services, staff and business. In addition to providing 
advice on professional issues, the IPU issued a number of guidelines and protocols to assist its 
members in compliance with legislation and in the provision of new services. IPU also provides 
a whole range of other support and advice to members and members are encouraged to avail of 
these services. The IPU’s business intelligence service hmR Ireland, which was launched in 2014 
to provide members with benchmarking reports for their businesses and to provide essential 
data to support IPU lobbying and policy proposals on behalf of members, continued to develop 
and evolve and by year-end had in  excess of 1,200 pharmacies sharing data. The value of the 
project was most clearly demonstrated when the IPU was able to calculate the precise cost to 
community pharmacy of the government’s ongoing reference pricing policy, as well as the impact 
on pharmacy revenues of the August 2016 Medicines Pricing and Supply framework agreement 
between the Department of Health, the HSE and the pharmaceutical industry, for the purposes 
of responding to the HSE’s Assessment of Pharmacy Fees in late 2017, and to support our 
analysis of the potential cost and resource benefit to the HSE of implementing proposed 
pharmacy services.
Review of the transactions and financial position of IPU, and an explanation of 
the salient features of the financial statements
IPU is conscious of the significant direct and indirect cuts that have been imposed on its members
over the past few years and continues to lobby actively to have those cuts reversed. IPU is also
conscious of the need to have a strong Union and a united voice to deal with the challenges we face
as a sector and a profession and we have worked hard to keep our costs under control and deliver
best value services and support to members.
It is important that IPU has sufficient funds to meet its liabilities and sufficient resources to promote
the professional and economic interests of members and to continue delivering services and supports
to them. The Executive Committee will keep the funding and resources of the IPU under continuous
review and will apply the resources to the continuing support, development and advancement of the
pharmacy profession and the interests of community pharmacy sector as a whole.
Eamon Daragh Connolly








AUDITORS REPORT TO 
IPU MEMBERS
Opinion
We have audited the financial statements 
of Irish Pharmacy Union for the year ended 
31 December 2018 which comprise the 
Statement of Comprehensive Income, 
the Statement Of Financial Position and 
the related notes. The relevant financial 
reporting framework that has been applied 
in their preparation is FRS 102 The Financial 
Reporting Standard applicable in the UK and 
Republic of Ireland.
In our opinion the financial 
statements:
• Give a true and fair view of the state of the 
entity’s affairs as at 31 December 2018 and 
of its loss for the year then ended; and
• Have been properly prepared in 
accordance with FRS 102 The Financial 
Reporting Standard applicable in the UK 
and Republic of Ireland.
Basis for opinion
We conducted our audit in accordance with 
International Standards on Auditing (Ireland) 
(ISAs (Ireland)) and relevant legal and 
regulatory requirements. Our responsibilities 
under those standards are further described 
in the Auditor’s responsibilities for the audit 
of the financial statements section of our 
report. We are independent of the entity in 
accordance with the ethical requirements 
that are relevant to our audit of financial 
statements in Ireland, including the Ethical 
Standard issued by the Irish Auditing and 
Accounting Supervisory Authority (IAASA), 
and we have fulfilled our other ethical
responsibilities in accordance with these 
requirements.
We believe that the audit evidence we have 
obtained is sufficient and appropriate to 
provide a basis for our opinion.
Conclusions relating to going concern
We have nothing to report in respect of the 
following matters in relation to which the ISAs 
(Ireland) require us to report to you where:
• The Officers’ use of the going concern basis 
of accounting in the preparation of the 
financial statements is not appropriate; or
• The Officers’ have not disclosed in the 
financial statements any identified material 
uncertainties that may cast significant 
doubt about the IPU’s ability to continue 
to adopt the going concern basis of 
accounting for a period of at least twelve 
months from the date when the financial 
statements are authorised for issue.
Other information
The IPU’s Officers are responsible for the other 
information. The other information comprises 
the information included in the annual report, 
other than the financial statements and our 
auditor’s report thereon. Our opinion on 
the financial statements does not cover the 
other information and, except to the extent 
otherwise explicitly stated in our report, we do 
not express any form of assurance conclusion 
thereon.
In connection with our audit of the financial 
statements, our responsibility is to read the 
other information and, in doing so, consider 
whether the other information is materially 
inconsistent with the financial statements or our 
knowledge obtained in the audit or otherwise 
appears to be materially misstated. If we identify 
such material inconsistencies or apparent 
material misstatements, we are required 
to determine whether there is a material 
misstatement in the financial statements or a 
material misstatement of the other information. 
If, based on the work we have performed, we 
conclude that there is a material misstatement 
of this other information, we are required to 
report that fact.
We have nothing to report in this regard.
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Opinions on other matters
Based solely on the work undertaken in the 
course of the audit, we report that in our 
opinion:
• The information given in the Officer’s 
Report is consistent with the financial 
statements; and
• The Officer’s Report has been prepared 
in accordance with applicable legal 
requirements.
We have obtained all the information and 
explanations which we consider necessary for 
the purposes of our audit.
In our opinion the accounting records of the 
IPU were sufficient to permit the financial 
statements to be readily and properly audited, 
and the financial statements are in agreement 
with the accounting records.
Based on the knowledge and understanding 
of the IPU and its environment obtained in 
the course of the audit, we have not identified 
any material misstatements in the Officers’ 
Report.
Matters on which we are required to report 
by the Industrial and Provident Societies Act 
1893 to 2018.
As required by Section 13(2) of the Industrial 
and Provident Societies Act 1893 to 2018, we 
examined the Statement of Financial Position 
showing the receipts and expenditure, funds 
and effect of the company, and verified same 
with the books, deeds, documents, accounts 
and vouching relating threats and found them 
to be correct, duly vouched and in accordance 
with law.
Responsibilities of Officers for the 
financial statements
As explained more fully in Statement of 
Responsibilities in the Officer’s Report, the 
Officers are responsible for the preparation 
of the financial statements and for being 
satisfied that they give a true and fair view, 
and for such internal control as the Officers 
determine is necessary to enable the 
preparation of financial statements that are 
free from material misstatement, whether 
due to fraud or error. 
In preparing the financial statements, the 
Officers are responsible for assessing the 
IPU’s ability to continue as a going concern, 
disclosing, as applicable, matters related to
going concern and using the going concern 
basis of accounting unless the Officers either 
intend to liquidate the entity or to cease 
operations, or have no realistic alternative but 
to do so.
Auditor’s responsibilities for the 
audit of the financial statements 
Our objectives are to obtain reasonable 
assurance about whether the financial 
statements as a whole are free from material 
misstatement, whether due to fraud or error, 
and to issue an auditor’s report that includes 
our opinion. Reasonable assurance is a high 
level of assurance, but is not a guarantee 
that an audit conducted in accordance with 
ISAs (Ireland)  will always detect a material 
misstatement when it exists. Misstatements 
can arise from fraud or error and are 
considered material if, individually or in the 
aggregate, they could reasonably be expected 
to influence the economic decisions of 
users taken on the basis of these financial 
statements.
A further description of our responsibilities 
for the audit of the financial statements 





ISA-700-(Ireland). This description forms 
part of our auditor’s report.
The purpose of our audit work and to 
whom we owe our responsibilities
This report is made solely to the IPU’s 
members, as a body. Our audit work has 
been undertaken so that we might state to 
the IPU’s members those matters we are 
required to state to them in an auditor’s 
report and for no other purpose. To the 
fullest extent permitted by law, we do not 
accept or assume responsibility to anyone 
other than the IPU and the IPU’s members 
as a body, for our audit work, for this report, 
or for the opinions we have formed.
Ian Lawlor
for and on behalf of JPA Brenson Lawlor 
12 May 2019
Chartered Accountants









2019 ANNUAL REPORT OF IPU EXECUTIVE COMMITTEE
38
  2018 2017 
 Notes € € 
Income 
Subscriptions  501,724 534,344 
Levy income  3,243,156 3,113,325 
Other income    239,107 158,565 
       3,983,987 3,806,234 
Expenditure 
Payroll and related expenses  1,939,227 1,895,001 
Travel and meetings  151,883 169,824 
Members’ expenses  180,730 153,491 
Subscriptions paid   65,623 60,603 
Depreciation    45,632 56,838 
Staff costs     8,122 6,730 
Other expenses   1,720,492 1,382,414
       4,111,709 3,724,901 
Operating (loss)/profit  (127,722) 81,333 
Fair value gain / (loss) on investments 6 (65,440) 6,609 
Gain / (loss) on disposal of investments  (6,821) 189,671 
Investment income  37,292 66,191 
Bank charges and fees  (4,696) (3,692)
(Loss)/Profit before taxation  (167,387) 340,112 
Tax       (322) (70,631)
(Loss)/Profit after taxation  (167,709) 269,481 
    
The Statement of Comprehensive Income has been prepared on the basis that all operations are continuing operations. 
PROFIT AND LOSS 
ACCOUNT    




   2018  
2017 
 Notes € € €  
€ 
Fixed assets 
Tangible assets 5  891,591   922,326
Financial assets 6  5,840,589   5,945,844
   6,732,180   6,868,170
Current assets 
Debtors 7 1,769,701  1,926,799 
Cash at bank and in hand  525,771  529,394 
  2,295,472  2,456,193 
Creditors: amounts falling due 
within one year 8 (229,287)  (358,290) 
   
Net current assets   2,066,185   2,097,903
Total assets less current liabilities   8,798,365   8,966,073
Capital and reserves 
Revaluation reserve 9  398,048   406,902
Profit and loss reserves 10  8,400,317   8,559,171
   
Total equity   8,798,365   8,966,073
 
The financial statements were approved by the officers and authorised for issue on 12 May 2019 and are signed on its behalf 
by:
Eamon Daragh Connolly Caitriona O’Riordan
President Honorary Treasurer
BALANCE SHEET 
AS AT 31 DECEMBER 2018
   




ANNUAL GENERAL MEETING MINUTES
Clayton Whites Hotel, Wexford 29 April 2018
1. The notice convening the meeting was taken as read.
2. The minutes of the 2017 AGM were taken as read.
3. The Report of the Directors on the Accounts for the year ended 31 December 2017, previously circulated, was 
taken as read.
4. The Auditors’ Report on the accounts for the year ended 31 December 2017, previously circulated, 
 was taken as read.
5.  The following motion was proposed by Michael Tierney, seconded by Brendan Quinn and carried unanimously: 
 “That this meeting agrees to the election of JPA Brenson Lawlor as Auditors for the IPU and IPU Services Ltd.”
6. The accounts were presented by the Treasurer and on the proposal of Michael Tierney seconded by Elizabeth Lang it 
was resolved:
 “That the Directors’ Report and Audited Statement of Accounts for the year ended 31 December 2017 as submitted to this 
meeting, be and are hereby adopted.”
 This motion was carried.
In conclusion, the Honorary Treasurer thanked Ciara Enright, Secretary to the Finance Committee, and her colleagues 
on the Committee for all their work over the past year and their continued oversight over the IPU finances. 









Eoghan Hanley  (Appointed 29 April 2018)
Caitríona O’Riordan  (Appointed 29 April 2018)
Secretary 
Darragh O’Loughlin


























FOR THE YEAR ENDED 31 DECEMBER 2018
The directors present their annual report and financial statements for the year ended 31 December 2018.
Principal activities
The principal activity of the company is the production of a yearbook and a monthly trade journal, the supply of drugs database 
information and the provision of business supports, courses and other CPD services to Irish Pharmacy Union members and 
their employees.
The results for the year ended 31 December 2018 are set out on page 7. The profit on ordinary 
activities for the year before taxation amounted to €306,505. After taxation of  €nil the profit of  €306,505 was 
transferred to Profit and Loss Reserves.
Directors and secretary 
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
 
Carmel Collins (Resigned 29 April 2018) 
Eamon Daragh Connolly  
Darragh O’Loughlin  
Stephen Nolan (Resigned 29 April 2018) 
Eoghan Hanly (Appointed 29 April 2018) 
Caitriona O’Riordan (Appointed 29 April 2018) 
Results and dividends 
The results for the year are set out on page 7.
 
No ordinary dividends were paid. The directors do not recommend payment of a final dividend.
 
Directors’ and secretary’s interests 
The directors’ and secretary’s interests in the shares of the company were as stated below:
 
                                                                                                     Ordinary shares of €1.27 each
  1 January 2018 31 December 2018
Carmel Collins - - 
Eamon Daragh  Connolly - - 
Darragh O’Loughlin - - 
Stephen Nolan - - 
Eoghan Hanly - - 
Caitriona O’Riordan - - 
Irish Pharmacy Union holds 100% of the issued share capital of the company.
Accounting records
The company’s directors are aware of their responsibilities, under sections 281 to 285 of the Companies Act 2014 as to 
whether in their opinion, the accounting records of the company are sufficient to permit the financial statements to be readily 
and properly audited and are discharging their responsibility by employing qualified and experienced staff, ensuring that 
sufficient company resources are available for the task and liaising with the company’s auditor.
The accounting records are held at the company’s registered office, Butterfield House, Butterfield Avenue, Rathfarnham, 
Dublin 14.
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DIRECTORS’ REPORT  
FOR THE YEAR ENDED 31 DECEMBER 2018
Post reporting date events
There are no post reporting date events which require disclosure.
Auditor
In accordance with the Companies Act 2014, section 383(2), JPA Brenson Lawlor offer their willingness to continue in office 
as auditor of the company.
Statement of disclosure to auditor
Each of the directors in office at the date of approval of this annual report confirms that:
• so far as the director is aware, there is no relevant audit information of which the company’s auditor is unaware, and
• the director has taken all the steps that he / she ought to have taken as a director in order to make himself / herself aware 
of any relevant audit information and to establish that the company’s auditor is aware of that information.
This confirmation is given and should be interpreted in accordance with the provisions of section 330
of the Companies Act 2014.
The entity has availed of the small companies exemption contained in the Companies Act 2014 with
regard to the requirements for exclusion of certain information in the Directors’ report.
On behalf of the Board
Eamon Daragh Connolly Darragh O’Loughlin
Director Director 




STATEMENT    
FOR THE YEAR ENDED 31 DECEMBER 2018
The directors are responsible for preparing the Directors’ Report and the financial statements in accordance with applicable 
Irish law and regulations.
Irish company law requires the directors to prepare financial statements for each financial year. Under that law, the 
directors have elected to prepare the financial statements in accordance with Companies Act 2014 and FRS 102 The 
Financial Reporting Standard applicable in the UK and Republic of Ireland (Generally accepted Accounting Practice in 
Ireland) issued by the Financial Reporting Council. Under company law, the directors must not approve the financial 
statements unless they are satisfied that they give a true and fair view of the assets, liabilities and financial position of the 
company as at the financial year end date and of the profit or loss of the company for that financial year and otherwise 
comply with the Companies Act 2014.
In preparing these financial statements, the directors are required to:
• select suitable accounting policies for the company financial statements and then apply them consistently;
• make judgements and estimates that are reasonable and prudent;
• state whether the financial statements have been prepared in accordance with applicable accounting standards, identify 
those standards, and note the effect and the reasons for any material departure from those standards; and
• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will 
continue in business.
The directors are responsible for ensuring that the company keeps or causes to be kept adequate accounting records which
correctly explain and record the transactions of the company, enable at any time the assets, liabilities, financial position 
and profit or loss ofthe company to be determined with reasonable accuracy, enable them to ensure that the financial
statements and  Directors’ Report comply with the Companies Act 2014 and enable the financial statements to be audited.
They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention
and detection of fraud and other irregularities.
Eamon Daragh Connolly Darragh O’Loughlin
Director Director 
12  May 2019 12  May 2019
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INDEPENDENT AUDITOR’S 
REPORT TO THE MEMBERS  
OF IPU SERVICES LIMITED
Opinion
We have audited the financial statements of IPU Services Limited (the ‘company’) for the year ended 31 December 2018 
which comprise the statement of comprehensive income, the statement of financial position and the related notes. The 
relevant financial reporting framework that has been applied in their preparation is the Companies Act 2014 and FRS 102 The 
Financial Reporting Standard applicable in the UK and Republic of Ireland.
In our opinion the financial statements:
• give a true and fair view of the state of the company’s affairs as at 31 December 2018 and of its profit for the year then 
ended;
• have been properly prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and 
Republic of Ireland; and
• have been prepared in accordance with the requirements of the Companies Act 2014.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (Ireland) (ISAs (Ireland)) and applicable law. 
Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial 
statements section of our report. We are independent of the company in accordance with the ethical requirements that are 
relevant to our audit of financial statements in Ireland, including the Ethical Standard issued by the Irish Auditing and
Accounting Supervisory Authority (IAASA), and we have fulfilled our other ethical responsibilities in accordance with these 
requirements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
We have nothing to report in respect of the following matters in relation to which the ISAs (Ireland) require us to report to 
you where:
• The directors’ use of the going concern basis of accounting in the preparation of the financial statements is not 
appropriate; or
• The directors have not disclosed in the financial statements any identified material uncertainties that may cast significant 
doubt about the company’s ability to continue to adopt the going concern basis of accounting for a period of at least 





The directors are responsible for the other information. The 
other information comprises the information included in 
the annual report, other than the financial statements and 
our auditor’s report thereon. Our opinion on the financial 
statements does not cover the other information and, except 
to the extent otherwise explicitly stated in our report, we do 
not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our 
responsibility is to read the other information and, in doing 
so, consider whether the other information is materially 
inconsistent with the financial statements or our knowledge 
obtained in the audit or otherwise appears to be materially 
misstated. If we identify such material inconsistencies 
or apparent material misstatements, we are required to 
determine whether there is a material misstatement in the 
financial statements or a material misstatement of the other 
information. If, based on the work we have performed, we 
conclude that there is a material misstatement of this other 
information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the 
Companies Act 2014
Based solely on the work undertaken in the course of the 
audit, we report that in our opinion:
• The information given in the directors’ report is 
consistent with the financial statements; and
• The directors’ report has been prepared in accordance 
with applicable legal requirements.
We have obtained all the information and explanations which 
we consider necessary for the purposes of our audit.
In our opinion the accounting records of the company were 
sufficient to permit the financial statements to be readily 
and properly audited, and the financial statements are in 
agreement with the accounting records.
Matters on which we are required to report by 
exception 
Based on the knowledge and understanding of the company 
and its environment obtained in the course of the audit, 
we have not identified any material misstatements in the 
directors’ report.
We have nothing to report in respect of our obligation under 
the Companies Act 2014 to report to you if, in our opinion, 
the disclosures of directors’ remuneration and transactions 
specified by sections 305 to 312 of the Act are not made.
Responsibilities of directors for the financial 
statements
As explained more fully in the directors’ responsibilities 
statement, the directors are responsible for the preparation 
of the financial statements and for being satisfied that they 
give a true and fair view, and for such internal control as the 
directors determine is necessary to enable the preparation 
of financial statements that are free from material 
misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are 
responsible for assessing the company’s ability to continue 
as a going concern, disclosing, as applicable, matters related 
to going concern and using the going concern basis of 
accounting unless the directors either intend to liquidate 
the company or to cease operations, or have no realistic 
alternative but to do so.
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Auditor’s responsibilities for the audit of the 
financial statements
Our objectives are to obtain reasonable assurance about 
whether the financial statements as a whole are free from 
material misstatement, whether due to fraud or error, 
and to issue an auditor’s report that includes our opinion. 
Reasonable assurance is a high level of assurance, but is not a 
guarantee that an audit conducted in accordance with ISAs 
(Ireland)  will always detect a material misstatement
when it exists. Misstatements can arise from fraud or 
error and are considered material if, individually or in the 
aggregate, they could reasonably be expected to influence 
the economic decisions of users taken on the basis of these 
financial statements.
A further description of our responsibilities for the audit of 




(Ireland). This description forms part of our auditor’s report.
The purpose of our audit work and to whom we 
owe our responsibilities
This report is made solely to the IPU’s members, as a body. 
Our audit work has been undertaken so that we might state 
to the IPU’s members those matters we are required to state 
to them in an auditor’s report and for no other purpose. To 
the fullest extent permitted by law, we do not accept or 
assume responsibility to anyone other than the IPU and the 
IPU’s members as a body, for our audit work, for this report, 
or for the opinions we have formed.
Ian Lawlor
for and on behalf of JPA Brenson Lawlor 12 May 2019
Chartered Accountants








  2018 2017 
 Notes € € 
Turnover  1,340,229 1,257,329  
Administrative expenses  (1,312,807) (1,186,358) 
Operating profit  27,422 70,971
Interest receivable and similar income 3 279,083 250,170 
Profit before taxation  306,505 321,141 
Tax on profit    (39,010) (41,381)
Profit for the financial year  267,495 279,760 
    
PROFIT AND LOSS 
ACCOUNT    
FOR THE YEAR ENDED 31 DECEMBER 2018
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   2018  2017 
 Notes € € € € 
Fixed assets 
Financial assets 4  345,000   345,000
Current assets 
Stocks 5
Debtors 6 49,719   55,236
Cash at bank and in hand  1,595,309   1,491,578 
  270,454   246,323
 
  1,915,482   1,793,137
Creditors: amounts falling due 
within one year 7 (1,897,365)   (2,042,515) 
   
Net current assets/ (liabilities)   18,117   (249,378) 
Total assets less current liabilities   363,117   95,622
Capital and reserves 
Called up share capitial
presented as equity 8  127   127
Profit and loss reserves   362,990   95,495
   
Total equity   363,117   95,622
 
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small 
companies’ regime and in accordance with Financial Reporting Statement 102 ‘The Financial Statement Reporting Standard 
applicable in the UK and Republic of Ireland’.
The financial statements were approved by the board of directors and authorised for issue on 12 May 2019 and are signed on 
its behalf by:
Eamon Daragh  Connolly Darragh O’Loughlin 
Director Director 
BALANCE SHEET 
AS AT 31 DECEMBER 2018
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